substance p has been researched along with Aspirin Induced Asthma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cvetković, G; Gaćeša, D; Perić, A; Vojvodić, D | 1 |
| Ewert, R; Felix, SB; Gläser, S; Gustavus, B; Koch, B; Kunkel, G; Noga, O; Schäper, C | 1 |
1 trial(s) available for substance p and Aspirin Induced Asthma
| Article | Year |
|---|---|
Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis.
Topics: Acetates; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Asthma, Aspirin-Induced; Cell Count; Cyclopropanes; Cysteine; Eosinophils; Female; Humans; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Nasal Lavage Fluid; Nasal Polyps; Neurokinin A; Quinolines; Substance P; Sulfides; Treatment Outcome | 2011 |
1 other study(ies) available for substance p and Aspirin Induced Asthma
| Article | Year |
|---|---|
Inflammatory mediators in nasal secretions of patients with nasal polyposis with and without aspirin sensitivity.
Topics: Aspirin; Asthma, Aspirin-Induced; Cross-Sectional Studies; Humans; Inflammation Mediators; Nasal Polyps; Rhinitis; Sinusitis; Substance P; Tryptases | 2023 |